ContractExecutive Employment Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2014 Company Industry JurisdictionThis Second Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into on February 25, 2014, to be effective as of January 1, 2014 (the “Effective Date”) by and between Mylan Inc. (the “Company” or “Mylan”) and Rajiv Malik (“Executive”).
ContractExecutive Employment Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2014 Company Industry JurisdictionThis Third Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into on February 25, 2014, to be effective as of January 1, 2014 (the “Effective Date”), by and between Mylan Inc. (the “Company”) and Robert J. Coury (the “Executive”).
ContractExecutive Employment Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2014 Company Industry JurisdictionThis Second Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into on February 25, 2014, to be effective as of January 1, 2014 (the “Effective Date”) by and between Mylan Inc. (the “Company” or “Mylan”) and Heather Bresch (“Executive”).
Mylan Inc. One-Time Special Five-Year Performance-Based Realizable Value Incentive Program Performance-Based Stock Appreciation Rights Award AgreementPerformance-Based Stock Appreciation Rights Award Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 28th, 2014 Company Industry JurisdictionMylan Inc., a Pennsylvania corporation (the “Company”), hereby grants to [l] (the “Participant”), effective as of [l] (the “Grant Date”), stock appreciation rights (the “SARs”) as set forth in this Award Agreement. The SARs are subject to the terms and conditions set forth in this Award Agreement and in the Company’s 2003 Long-Term Incentive Plan, as amended (the “Plan”). In the event of any inconsistency between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall govern except to the extent specifically set forth herein. Capitalized terms used but not defined in this Award Agreement (including Exhibit A hereto) shall have the meanings ascribed to them in the Plan. Notwithstanding the foregoing, the SARs shall be subject to any term of any employment agreement between the Company and the Participant that specifically references this Award Agreement (but, for the avoidance of doubt, shall not be subject to any other terms in such agreement or in any
AMENDMENT NO. 6 TO RETIREMENT BENEFIT AGREEMENTRetirement Benefit Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2014 Company Industry JurisdictionTHIS AMENDMENT NO. 6 TO RETIREMENT BENEFIT AGREEMENT (this “Amendment”) by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Robert J. Coury (“Executive”) is made effective as of January 1, 2014 (the “Effective Date”).
Mylan Inc. One-Time Special Five-Year Performance-Based Realizable Value Incentive Program Performance-Based Restricted Stock Unit Award AgreementPerformance-Based Restricted Stock Unit Award Agreement • February 28th, 2014 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 28th, 2014 Company Industry JurisdictionNotwithstanding the foregoing, in the event the closing price of a share of Common Stock on the NASDAQ (or such other exchange on which the Common Stock is then listed) has equaled or exceeded the Maximum Share Value per share on any 10 trading days in any trailing 60 trading day period prior to the relevant settlement date, the Share Price Multiplier and the Value Creation Multiplier shall, thereafter and for all purposes hereunder, be determined based on the closing price of a share of Common Stock as of the end of such 10th trading day.